BIOTRANSPORT
Dead / Cancelled — Cancelled — Section 8 (as of 03 May 2013)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 75270967
- Registration number
- 2628465
- Mark type
- Word mark
- Filed
- 08 Apr 1997
- Published for opposition
- 13 Apr 1999
- Registered
- 01 Oct 2002
- Attorney of record
- Catherine M. Clayton
Goods and services
- Class 042 — Scientific and technological services: pharmaceutical product research and development
Owner
- Supratek Pharma Inc., Montreal, QC, CA
- Supratek Pharma Inc., Montreal, QC, CA
- Supratek Pharma Inc., Montreal, QC, CA
Prosecution history
- 03 May 2013 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 04 Apr 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Apr 2009 — ASSIGNED TO PARALEGAL
- 31 Mar 2009 — TEAS SECTION 8 & 15 RECEIVED
- 01 Feb 2008 — CASE FILE IN TICRS
- 04 Dec 2007 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Dec 2007 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Oct 2002 — REGISTERED-PRINCIPAL REGISTER
- 29 Mar 2002 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Jul 2001 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 14 Nov 2000 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Nov 2000 — ASSIGNED TO EXAMINER
- 02 Nov 2000 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Oct 2000 — SOU EXTENSION 2 GRANTED
- 30 Jun 2000 — USE AMENDMENT FILED